Selected research
Market Outlook & Growth Opportunities
Global Mobile In-Home NAD IV Therapy Market Outlook and Growth Opportunities 2026
Market perspective
The global Mobile In-Home NAD IV Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Mobile In-Home NAD IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Mobile In-Home NAD IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mobile In-Home NAD IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Mobile In-Home NAD IV Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Mobile In-Home NAD IV Therapy market include Toronto Functional Medicine Centre, Thedripclub, The Wellness Lab, Seaside Skin Care, Rocky Mountain Ivmedics, Reset IV, Premiumhealth, Nadclinic and Mobileivmedics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Mobile In-Home NAD IV Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mobile In-Home NAD IV Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mobile In-Home NAD IV Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Mobile In-Home NAD IV Therapy market.
Mobile In-Home NAD IV Therapy Segment by Company
Toronto Functional Medicine Centre
Thedripclub
The Wellness Lab
Seaside Skin Care
Rocky Mountain Ivmedics
Reset IV
Premiumhealth
Nadclinic
Mobileivmedics
LIVV Natural
IV Boost UK
Hydrate IV Bar
Effect Doctors
Conciergemdla
BioReset Medical
Azivmedics
Mobile In-Home NAD IV Therapy Segment by Type
NAD+ Mixed Vitamin Injections
Pure NAD+ Injection
Mobile In-Home NAD IV Therapy Segment by Application
Clinic
Hospital
Home
Mobile In-Home NAD IV Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Mobile In-Home NAD IV Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Mobile In-Home NAD IV Therapy key companies, revenue, market share, and recent developments.
3. To split the Mobile In-Home NAD IV Therapy breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Mobile In-Home NAD IV Therapy market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Mobile In-Home NAD IV Therapy significant trends, drivers, influence factors in global and regions.
6. To analyze Mobile In-Home NAD IV Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mobile In-Home NAD IV Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mobile In-Home NAD IV Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mobile In-Home NAD IV Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mobile In-Home NAD IV Therapy industry.
Chapter 3: Detailed analysis of Mobile In-Home NAD IV Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Mobile In-Home NAD IV Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Mobile In-Home NAD IV Therapy in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- NAD+ Mixed Vitamin Injections
- Pure NAD+ Injection
Applications
- Clinic
- Hospital
- Home
Companies covered
- Toronto Functional Medicine Centre
- Thedripclub
- The Wellness Lab
- Seaside Skin Care
- Rocky Mountain Ivmedics
- Reset IV
- Premiumhealth
- Nadclinic
- Mobileivmedics
- LIVV Natural
- IV Boost UK
- Hydrate IV Bar
- Effect Doctors
- Conciergemdla
- BioReset Medical
- Azivmedics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Mobile In-Home NAD IV Therapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Mobile In-Home NAD IV Therapy Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Mobile In-Home NAD IV Therapy Market Dynamics
- 2.1 Mobile In-Home NAD IV Therapy Industry Trends
- 2.2 Mobile In-Home NAD IV Therapy Industry Drivers
- 2.3 Mobile In-Home NAD IV Therapy Industry Opportunities and Challenges
- 2.4 Mobile In-Home NAD IV Therapy Industry Restraints
3 Mobile In-Home NAD IV Therapy Market by Company
- 3.1 Global Mobile In-Home NAD IV Therapy Company Revenue Ranking in 2025
- 3.2 Global Mobile In-Home NAD IV Therapy Revenue by Company (2021-2026)
- 3.3 Global Mobile In-Home NAD IV Therapy Company Ranking (2024-2026)
- 3.4 Global Mobile In-Home NAD IV Therapy Company Manufacturing Base and Headquarters
- 3.5 Global Mobile In-Home NAD IV Therapy Company Product Type and Application
- 3.6 Global Mobile In-Home NAD IV Therapy Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Mobile In-Home NAD IV Therapy Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Mobile In-Home NAD IV Therapy Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Mobile In-Home NAD IV Therapy Market by Type
- 4.1 Mobile In-Home NAD IV Therapy Type Introduction
- 4.1.1 NAD+ Mixed Vitamin Injections
- 4.1.2 Pure NAD+ Injection
- 4.2 Global Mobile In-Home NAD IV Therapy Sales Value by Type
- 4.2.1 Global Mobile In-Home NAD IV Therapy Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Mobile In-Home NAD IV Therapy Sales Value by Type (2021-2032)
- 4.2.3 Global Mobile In-Home NAD IV Therapy Sales Value Share by Type (2021-2032)
5 Mobile In-Home NAD IV Therapy Market by Application
- 5.1 Mobile In-Home NAD IV Therapy Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Home
- 5.2 Global Mobile In-Home NAD IV Therapy Sales Value by Application
- 5.2.1 Global Mobile In-Home NAD IV Therapy Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Mobile In-Home NAD IV Therapy Sales Value by Application (2021-2032)
- 5.2.3 Global Mobile In-Home NAD IV Therapy Sales Value Share by Application (2021-2032)
6 Mobile In-Home NAD IV Therapy Regional Value Analysis
- 6.1 Global Mobile In-Home NAD IV Therapy Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Mobile In-Home NAD IV Therapy Sales Value by Region (2021-2032)
- 6.2.1 Global Mobile In-Home NAD IV Therapy Sales Value by Region: 2021-2026
- 6.2.2 Global Mobile In-Home NAD IV Therapy Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Mobile In-Home NAD IV Therapy Sales Value (2021-2032)
- 6.3.2 North America Mobile In-Home NAD IV Therapy Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Mobile In-Home NAD IV Therapy Sales Value (2021-2032)
- 6.4.2 Europe Mobile In-Home NAD IV Therapy Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Mobile In-Home NAD IV Therapy Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Mobile In-Home NAD IV Therapy Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Mobile In-Home NAD IV Therapy Sales Value (2021-2032)
- 6.6.2 South America Mobile In-Home NAD IV Therapy Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Mobile In-Home NAD IV Therapy Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Mobile In-Home NAD IV Therapy Sales Value Share by Country, 2025 VS 2032
7 Mobile In-Home NAD IV Therapy Country-level Value Analysis
- 7.1 Global Mobile In-Home NAD IV Therapy Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Mobile In-Home NAD IV Therapy Sales Value by Country (2021-2032)
- 7.2.1 Global Mobile In-Home NAD IV Therapy Sales Value by Country (2021-2026)
- 7.2.2 Global Mobile In-Home NAD IV Therapy Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.7.2 France Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.14.2 China Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.17.2 India Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Mobile In-Home NAD IV Therapy Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Mobile In-Home NAD IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Mobile In-Home NAD IV Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Toronto Functional Medicine Centre
- 8.1.1 Toronto Functional Medicine Centre Company Information
- 8.1.2 Toronto Functional Medicine Centre Business Overview
- 8.1.3 Toronto Functional Medicine Centre Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.1.4 Toronto Functional Medicine Centre Mobile In-Home NAD IV Therapy Product Portfolio
- 8.1.5 Toronto Functional Medicine Centre Recent Developments
- 8.2 Thedripclub
- 8.2.1 Thedripclub Company Information
- 8.2.2 Thedripclub Business Overview
- 8.2.3 Thedripclub Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.2.4 Thedripclub Mobile In-Home NAD IV Therapy Product Portfolio
- 8.2.5 Thedripclub Recent Developments
- 8.3 The Wellness Lab
- 8.3.1 The Wellness Lab Company Information
- 8.3.2 The Wellness Lab Business Overview
- 8.3.3 The Wellness Lab Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.3.4 The Wellness Lab Mobile In-Home NAD IV Therapy Product Portfolio
- 8.3.5 The Wellness Lab Recent Developments
- 8.4 Seaside Skin Care
- 8.4.1 Seaside Skin Care Company Information
- 8.4.2 Seaside Skin Care Business Overview
- 8.4.3 Seaside Skin Care Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.4.4 Seaside Skin Care Mobile In-Home NAD IV Therapy Product Portfolio
- 8.4.5 Seaside Skin Care Recent Developments
- 8.5 Rocky Mountain Ivmedics
- 8.5.1 Rocky Mountain Ivmedics Company Information
- 8.5.2 Rocky Mountain Ivmedics Business Overview
- 8.5.3 Rocky Mountain Ivmedics Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.5.4 Rocky Mountain Ivmedics Mobile In-Home NAD IV Therapy Product Portfolio
- 8.5.5 Rocky Mountain Ivmedics Recent Developments
- 8.6 Reset IV
- 8.6.1 Reset IV Company Information
- 8.6.2 Reset IV Business Overview
- 8.6.3 Reset IV Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.6.4 Reset IV Mobile In-Home NAD IV Therapy Product Portfolio
- 8.6.5 Reset IV Recent Developments
- 8.7 Premiumhealth
- 8.7.1 Premiumhealth Company Information
- 8.7.2 Premiumhealth Business Overview
- 8.7.3 Premiumhealth Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.7.4 Premiumhealth Mobile In-Home NAD IV Therapy Product Portfolio
- 8.7.5 Premiumhealth Recent Developments
- 8.8 Nadclinic
- 8.8.1 Nadclinic Company Information
- 8.8.2 Nadclinic Business Overview
- 8.8.3 Nadclinic Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.8.4 Nadclinic Mobile In-Home NAD IV Therapy Product Portfolio
- 8.8.5 Nadclinic Recent Developments
- 8.9 Mobileivmedics
- 8.9.1 Mobileivmedics Company Information
- 8.9.2 Mobileivmedics Business Overview
- 8.9.3 Mobileivmedics Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.9.4 Mobileivmedics Mobile In-Home NAD IV Therapy Product Portfolio
- 8.9.5 Mobileivmedics Recent Developments
- 8.10 LIVV Natural
- 8.10.1 LIVV Natural Company Information
- 8.10.2 LIVV Natural Business Overview
- 8.10.3 LIVV Natural Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.10.4 LIVV Natural Mobile In-Home NAD IV Therapy Product Portfolio
- 8.10.5 LIVV Natural Recent Developments
- 8.11 IV Boost UK
- 8.11.1 IV Boost UK Company Information
- 8.11.2 IV Boost UK Business Overview
- 8.11.3 IV Boost UK Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.11.4 IV Boost UK Mobile In-Home NAD IV Therapy Product Portfolio
- 8.11.5 IV Boost UK Recent Developments
- 8.12 Hydrate IV Bar
- 8.12.1 Hydrate IV Bar Company Information
- 8.12.2 Hydrate IV Bar Business Overview
- 8.12.3 Hydrate IV Bar Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.12.4 Hydrate IV Bar Mobile In-Home NAD IV Therapy Product Portfolio
- 8.12.5 Hydrate IV Bar Recent Developments
- 8.13 Effect Doctors
- 8.13.1 Effect Doctors Company Information
- 8.13.2 Effect Doctors Business Overview
- 8.13.3 Effect Doctors Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.13.4 Effect Doctors Mobile In-Home NAD IV Therapy Product Portfolio
- 8.13.5 Effect Doctors Recent Developments
- 8.14 Conciergemdla
- 8.14.1 Conciergemdla Company Information
- 8.14.2 Conciergemdla Business Overview
- 8.14.3 Conciergemdla Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.14.4 Conciergemdla Mobile In-Home NAD IV Therapy Product Portfolio
- 8.14.5 Conciergemdla Recent Developments
- 8.15 BioReset Medical
- 8.15.1 BioReset Medical Company Information
- 8.15.2 BioReset Medical Business Overview
- 8.15.3 BioReset Medical Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.15.4 BioReset Medical Mobile In-Home NAD IV Therapy Product Portfolio
- 8.15.5 BioReset Medical Recent Developments
- 8.16 Azivmedics
- 8.16.1 Azivmedics Company Information
- 8.16.2 Azivmedics Business Overview
- 8.16.3 Azivmedics Mobile In-Home NAD IV Therapy Revenue and Gross Margin (2021-2026)
- 8.16.4 Azivmedics Mobile In-Home NAD IV Therapy Product Portfolio
- 8.16.5 Azivmedics Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst